{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:13:21Z","timestamp":1793171601066,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["18OKK36"],"award-info":[{"award-number":["18OKK36"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007658","name":"Baxter Healthcare Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005039","name":"Leids Universitair Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013964","name":"Stiftelsen Stig och Gunborg Westman","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009009","name":"Novartis Pharmaceuticals Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ahj.2019.06.019","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T19:16:31Z","timestamp":1562354191000},"page":"20-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post\u2013myocardial infarction patients"],"prefix":"10.1016","volume":"216","author":[{"given":"Edouard L.","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael Andersson","family":"Franko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Obergfell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedo W.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Gabrielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Jernberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jes\u00fas","family":"Carrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2019.06.019_bb0005","doi-asserted-by":"crossref","unstructured":"Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, et\u00a0al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2019:CIR0000000000000664.","DOI":"10.1161\/CIR.0000000000000664"},{"issue":"13","key":"10.1016\/j.ahj.2019.06.019_bb0010","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"9844","key":"10.1016\/j.ahj.2019.06.019_bb0015","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study","volume":"380","author":"Tonelli","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2019.06.019_bb0020","doi-asserted-by":"crossref","unstructured":"Chronic Kidney Disease Prognosis C, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et\u00a0al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073\u201381.","DOI":"10.1016\/S0140-6736(10)60674-5"},{"issue":"11","key":"10.1016\/j.ahj.2019.06.019_bb0025","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archinte.167.11.1130","article-title":"Cardiovascular disease and subsequent kidney disease","volume":"167","author":"Elsayed","year":"2007","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.ahj.2019.06.019_bb0030","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.atherosclerosis.2008.08.016","article-title":"Clinical and subclinical cardiovascular disease and kidney function decline in the elderly","volume":"204","author":"Shlipak","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2019.06.019_bb0035","doi-asserted-by":"crossref","unstructured":"George LK, Koshy SKG, Molnar MZ, Thomas F, Lu JL, Kalantar-Zadeh K, et\u00a0al. Heart failure increases the risk of adverse renal outcomes in patients with normal kidney function. Circ Heart Fail. 2017;10(8).","DOI":"10.1161\/CIRCHEARTFAILURE.116.003825"},{"issue":"9","key":"10.1016\/j.ahj.2019.06.019_bb0040","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ahj.2019.06.019_bb0045","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ki.2011.178","article-title":"Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease","volume":"80","author":"Swaminathan","year":"2011","journal-title":"Kidney Int"},{"issue":"46","key":"10.1016\/j.ahj.2019.06.019_bb0050","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1093\/eurheartj\/ehy633","article-title":"Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions","volume":"39","author":"Kalkman","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2019.06.019_bb0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ahj.2018.07.014","article-title":"High-sensitivity C-reactive protein elevation in patients with prior myocardial infarction in the United States","volume":"204","author":"Pagidipati","year":"2018","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.ahj.2019.06.019_bb0060","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCRESAHA.116.310527","article-title":"How common is residual inflammatory risk?","volume":"120","author":"Ridker","year":"2017","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.ahj.2019.06.019_bb0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.118.034645","article-title":"Residual inflammatory risk on treatment with PCSK9 inhibition and statin therapy","volume":"138","author":"Pradhan","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahj.2019.06.019_bb0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.118.034032","article-title":"Inflammatory and cholesterol risk in the FOURIER trial","volume":"138","author":"Bohula","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ahj.2019.06.019_bb0075","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1523-1755.2004.00481.x","article-title":"Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease","volume":"65","author":"Eustace","year":"2004","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.ahj.2019.06.019_bb0080","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2215\/CJN.03500412","article-title":"Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC","volume":"7","author":"Gupta","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ahj.2019.06.019_bb0085","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/j.ajkd.2018.09.012","article-title":"Use of measures of inflammation and kidney function for prediction of atherosclerotic vascular disease events and death in patients with CKD: findings from the CRIC study","volume":"73","author":"Amdur","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.ahj.2019.06.019_bb0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ckj\/sfv117","article-title":"The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness","volume":"9","author":"Runesson","year":"2016","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1016\/j.ahj.2019.06.019_bb0095","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1373\/clinchem.2008.120642","article-title":"Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER study","volume":"55","author":"Glynn","year":"2009","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.ahj.2019.06.019_bb0100","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2019.06.019_bb0105","unstructured":"Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney inter, Suppl.\u00a02013;3:1\u2013150."},{"key":"10.1016\/j.ahj.2019.06.019_bb0110","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ahj.2019.06.019_bb0115","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney inter, Suppl.\u00a02012;2:1\u2013138."},{"issue":"21","key":"10.1016\/j.ahj.2019.06.019_bb0120","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.jacc.2018.03.490","article-title":"Inhibition of interleukin-1beta by canakinumab and cardiovascular outcomes in patients with chronic kidney disease","volume":"71","author":"Ridker","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10118","key":"10.1016\/j.ahj.2019.06.019_bb0125","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"issue":"9709","key":"10.1016\/j.ahj.2019.06.019_bb0130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Emerging Risk Factors","year":"2010","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ahj.2019.06.019_bb0135","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/ki.2011.283","article-title":"Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study","volume":"80","author":"Shankar","year":"2011","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.ahj.2019.06.019_bb0140","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1046\/j.1523-1755.2003.00762.x","article-title":"C-reactive protein is associated with renal function abnormalities in a non-diabetic population","volume":"63","author":"Stuveling","year":"2003","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ahj.2019.06.019_bb0145","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00398.x","article-title":"Cholesterol, et\u00a0al. Biomarkers of inflammation and progression of chronic kidney disease","volume":"68","author":"Tonelli","year":"2005","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.ahj.2019.06.019_bb0150","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1093\/ndt\/gfw354","article-title":"Prevalence and recognition of chronic kidney disease in Stockholm healthcare","volume":"31","author":"Gasparini","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"20","key":"10.1016\/j.ahj.2019.06.019_bb0155","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/archinte.168.20.2268","article-title":"Patient awareness of chronic kidney disease: trends and predictors","volume":"168","author":"Plantinga","year":"2008","journal-title":"Arch Intern Med"},{"issue":"22","key":"10.1016\/j.ahj.2019.06.019_bb0160","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1136\/heartjnl-2015-307773","article-title":"Acute kidney injury in patients with acute coronary syndromes","volume":"101","author":"Marenzi","year":"2015","journal-title":"Heart"},{"issue":"19","key":"10.1016\/j.ahj.2019.06.019_bb0165","article-title":"Combination of amino-terminal pro-BNP, estimated GFR, and high-sensitivity CRP for predicting cardiorenal syndrome type 1 in acute myocardial infarction patients","volume":"7","author":"Zhang","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.ahj.2019.06.019_bb0170","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.athoracsur.2017.01.075","article-title":"C-reactive protein predicts acute kidney injury and death after coronary artery bypass grafting","volume":"104","author":"Han","year":"2017","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.ahj.2019.06.019_bb0175","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1172\/JCI200215606","article-title":"TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity","volume":"110","author":"Ramesh","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.ahj.2019.06.019_bb0180","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0041-1345(98)00666-6","article-title":"Cytokine-regulated expression of vascular cell adhesion molecule-1 in human glomerular endothelial cells","volume":"30","author":"Park","year":"1998","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.ahj.2019.06.019_bb0185","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1046\/j.1523-1755.2001.00071.x","article-title":"Renal cortical cholesterol accumulation is an integral component of the systemic stress response","volume":"60","author":"Zager","year":"2001","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.ahj.2019.06.019_bb0190","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/ki.1992.183","article-title":"Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1","volume":"41","author":"Nakamura","year":"1992","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.ahj.2019.06.019_bb0195","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.4049\/jimmunol.143.12.3949","article-title":"Involvement of IL-6 in mesangial proliferative glomerulonephritis","volume":"143","author":"Horii","year":"1989","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.ahj.2019.06.019_bb0200","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/ki.1992.91","article-title":"Interleukin-6: an autocrine regulator of mesangial cell growth","volume":"41","author":"Coleman","year":"1992","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ahj.2019.06.019_bb0205","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ki.2014.271","article-title":"Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy","volume":"87","author":"Shahzad","year":"2015","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.ahj.2019.06.019_bb0210","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1681\/ASN.V94614","article-title":"Role of IL-1 in renal ischemic reperfusion injury","volume":"9","author":"Haq","year":"1998","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ahj.2019.06.019_bb0215","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/01.ASN.0000115704.86897.F4","article-title":"Contributions of IL-1beta and IL-1alpha to crescentic glomerulonephritis in mice","volume":"15","author":"Timoshanko","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ahj.2019.06.019_bb0220","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0272-6386(97)90495-9","article-title":"Interleukin-1 receptor antagonist modulates the progression of a spontaneously occurring IgA nephropathy in mice","volume":"30","author":"Chen","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"46","key":"10.1016\/j.ahj.2019.06.019_bb0225","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1093\/eurheartj\/ehy723","article-title":"Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention?","volume":"39","author":"Ridker","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2019.06.019_bb0230","doi-asserted-by":"crossref","unstructured":"Carrero JJ, Andersson Franko M, Obergfell A, Gabrielsen A, Jernberg T. hsCRP level and the risk of death or recurrent cardiovascular events in patients with myocardial infarction: a healthcare-based study. J Am Heart Assoc. 2019;8(11):e012638.","DOI":"10.1161\/JAHA.119.012638"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319301723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319301723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:57:25Z","timestamp":1762077445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870319301723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":46,"alternative-id":["S0002870319301723"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2019.06.019","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post\u2013myocardial infarction patients","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2019.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}